Agentic AI models are reshaping pharmaceutical workflows with impacts that extend beyond simple productivity improvements, according to reporting in Pharmaceutical Executive. The analysis examines how autonomous AI agents are influencing drug development processes, regulatory compliance, and operational procedures across the pharmaceutical industry.